Please join Georgia Bio’s Emerging Leaders Network for our next Industry Tour at Metaclipse Therapeutics.
Metaclipse Therapeutics is a preclinical-stage biotechnology company developing MembrexTM, a novel cancer immunotherapy tailored to each patient and their specific tumor. Metaclipse intends to commercialize its products through licensing agreements with major pharmaceutical companies after establishing safety and effectiveness.
Visit Metaclipse Therapeutics at http://www.metaclipsetherapeutics.com
Closed-toe shoes and pants ARE required for this tour.